| Bioactivity | Diethyl-Lodoxamide is a highly potent GPR35 agonist with potential to inhibit inflammatory bowel disease. Diethyl-Lodoxamide activates GPR35 in humans, mice and rats, showing similar EC50 values. Diethyl-Lodoxamide can alleviate the clinical symptoms of DSS-induced inflammatory bowel disease in mouse models, and the effect is better than the traditional drug 5-ASA. The pharmaceutical properties of Diethyl-Lodoxamide have been optimized to better meet the requirements of drug design[1]. |
| CAS | 53882-13-6 |
| Formula | C15H14ClN3O6 |
| Molar Mass | 367.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD |
Diethyl-Lodoxamide
CAS: 53882-13-6 F: C15H14ClN3O6 W: 367.74
Diethyl-Lodoxamide is a highly potent GPR35 agonist with potential to inhibit inflammatory bowel disease. Diethyl-Lodoxa
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.